Model Predicts Erectile Function After Prostate Cancer Therapy

Patient, treatment characteristics used to predict erectile function two years post cancer treatment

TUESDAY, Sept. 20 (HealthDay News) -- Erectile function two years after prostate cancer treatment can be predicted based on patient and treatment characteristics, according to a study published in the Sept. 21 issue of the Journal of the American Medical Association.

Mehrdad Alemozaffar, M.D., from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, and colleagues developed a validated model to predict erectile function two years after prostate cancer treatment. Models were developed using pretreatment patient characteristics, sexual health-related quality of life (HRQOL), and treatment details from patients in an academic cohort (from 2003 to 2006), and were validated in a community-based cohort (from 1995 to 2007). Patient-reported sexual functionality two years following cancer treatment was the main outcome measure.

The investigators found that at two years after prostate cancer treatment, the use of medication or devices for erectile dysfunction was reported in 37 percent of all patients; 48 percent of those with functional erections before treatment reported functional erections, as did 53 percent of those without penile prostheses. Functional erections two years after treatment were correlated with pretreatment sexual HRQOL score, age, serum prostate-specific antigen level, race/ethnicity, body mass index, and intended treatment details. Models estimated two-year function probabilities from 10 percent or less to 70 percent or greater, depending on pretreatment patient characteristics and treatment detail. The models performed well in functional prediction in the validation cohort.

"Stratification by pretreatment patient characteristics and treatment details enables prediction of erectile function two years after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text
Editorial (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Blunt Chest Trauma
Journal of Trauma Nursing, November/December 2014
Expires: 12/31/2016 CE:2 $21.95


The School Age Child with Congenital Heart Disease
MCN, The American Journal of Maternal/Child Nursing, January/February 2015
Expires: 2/28/2017 CE:2.5 $24.95


Understanding multiple myeloma
Nursing Made Incredibly Easy!, January/February 2015
Expires: 2/28/2017 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles

Comprehensive Care: Looking Beyond the Presenting Problem
Journal of Christian Nursing, January/March 2015
Free access will expire on March 2, 2015.


Pain and Alzheimer dementia: A largely unrecognized problem
Nursing Made Incredibly Easy!, January/February 2015
Free access will expire on February 16, 2015.


Glycemic control in hospitalized patients
Nursing2015 Critical Care, January 2015
Free access will expire on February 16, 2015.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events